Testing a new pain drug for shingles pain
Treatments studied
Part of Infections, Pain clinical trials.
This trial tests a new pain medication called tulodesvenlafaxine for people with shingles-related pain. It may help if you have moderate to severe pain that started within the last 90 days.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- Your shingles rash must have started within the last 90 days.
- You must have moderate to severe shingles pain (score of 4 or more on a 0–10 pain scale).
- Your liver and kidney function must be within acceptable limits (checked by blood tests).
- You should not have other ongoing pain conditions or serious illnesses like immune disorders, organ transplant, or cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if desvenlafaxine (an antidepressant also used for nerve pain) can safely reduce pain from shingles. It may be an option if your shingles pain is moderate to severe and started within the last 3 months.
This trial tests a new medicine called crisugabalin to see if it safely reduces shingles pain. It may help if you have moderate to severe pain from a shingles rash that started less than 3 months ago.
This trial tests if the antidepressant venlafaxine can prevent long-term nerve pain (postherpetic neuralgia) in people who currently have shingles. If you have moderate to severe shingles pain, this study may help find a way to stop the pain from becoming chronic.
This trial tests if a flurbiprofen skin patch can reduce pain from shingles (herpes zoster). It may help people with moderate to severe pain who have had the rash for less than 90 days.
This trial tests if a loxoprofen skin patch (a non-steroidal anti-inflammatory drug) can safely relieve moderate to severe pain from shingles. It may be an option for people who have had shingles rash for less than 90 days.
This study tests a combination of a nasal spray medicine (esketamine) and a nerve treatment (pulsed radiofrequency) to reduce severe shingles pain. It may help people who have had shingles pain for less than 3 months and are already scheduled for the nerve procedure.
Hear when a new Herpes Zoster trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.